70 web-developer-university-of-liverpool Postdoctoral positions at KINGS COLLEGE LONDON in Uk
- 
                
                
                of a vibrant multi-disciplinary research group operating across different research themes in cardiac biology, having the specific aim to develop technologies for gene editing of cardiovascular 
- 
                
                
                (pro-rata) for professional development. This entitlement, from the Concordat to Support the Career Development of Researchers , applies to Postdocs, Research Assistants, Research and Teaching 
- 
                
                
                January 2026 until 31 December 2028. Research staff at King’s are entitled to at least 10 days per year (pro-rata) for professional development. This entitlement, from the Concordat to Support the Career 
- 
                
                
                -specific molecular pathways can be identified that are suitable as potential drug targets in ARHL. The post-holder will work in the lab of Dr Lisa Nolan to support the development of a single-cell RNA-Seq 
- 
                
                
                year (pro-rata) for professional development. This entitlement, from the Concordat to Support the Career Development of Researchers , applies to Postdocs, Research Assistants, Research and Teaching 
- 
                
                
                from 1st January 2026 until 31 December 2028. Research staff at King’s are entitled to at least 10 days per year (pro-rata) for professional development. This entitlement, from the Concordat to Support 
- 
                
                
                potential drug targets in ARHL. The post-holder will work in the lab of Dr Lisa Nolan to support the development of a single-cell RNA-Seq pipeline for cochlear tissue that is suitable to translate to our 
- 
                
                
                bacterial infections. About the role The bacterial pathogen Klebsiella pneumoniae (Kp) is a major antibiotic-resistant pathogen responsible for high levels of mortality worldwide. Development of novel 
- 
                
                
                pathogen Klebsiella pneumoniae (Kp) is a major antibiotic-resistant pathogen responsible for high levels of mortality worldwide. Development of novel therapies and preventative vaccines is hampered by 
- 
                
                
                . Development of novel therapies and preventative vaccines is hampered by an incomplete understanding of the pathogenesis of Kp infection. The extracellular polysaccharide capsule is a major Kp virulence